Learning to live with COVID-19
Can COVID-19 push us towards the unthinkable: a patent-free vaccine or patent-free drug?
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Gilead Sciences
US FDA issues EUA for remdesivir for COVID-19 treatment
The EUA allows for remdesivir to be distributed in the US and administered intravenously by healthcare providers, as appropriate,…
Gilead’s suspension of Covid-19 trials in China should serve as bellwether for studies in other…
Selection of trial sites where the outbreak is growing, possibly in regions where implementation of control measures has been…
Trial of Gilead’s potential coronavirus treatment running ahead of schedule – researcher
Preliminary findings from the randomized trial of the antiviral drug remdesivir, begun in February by the National Institute of…
Gilead disputes report that its drug flopped in leaked coronavirus trial
In the Chinese trial remdesivir, given by intravenous infusion, failed to improve patients’ condition or reduce the pathogen’s…
Gilead Sciences awards grants to address HIV challenges in India
Four Indian recipients out of 39 submissions to receive the grant
Gilead Sciences announced the recipients of its 2019 Gilead…
Glenmark Pharmaceuticals receives ANDA approval for Ranolazine
Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg are a generic version of Ranexa Extended-Release Tablets, 500 mg and…
Gilead Sciences announces launch of Asia Pacific Rainbow Grants Program in India
This year’s grants program seeks to improve the quality of life of people living with HIV by focusing on three priority areas
Natco settles patent suit with Gilead, others
Under the terms of the settlement, Natco's partner Alvogen will be able to market the oseltamivir phosphate capsules
Natco Pharma…
Gilead Sciences keen to set up unit in Hyderabad
The unit is likely to come up in proposed 'Pharma City'